Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1115

1.

Multicystic and well-differentiated papillary peritoneal mesothelioma treated by surgical cytoreduction and hyperthermic intra-peritoneal chemotherapy (HIPEC).

Baratti D, Kusamura S, Nonaka D, Oliva GD, Laterza B, Deraco M.

Ann Surg Oncol. 2007 Oct;14(10):2790-7. Epub 2007 Jul 28.

PMID:
17661150
2.

Multicystic peritoneal mesothelioma treated by surgical cytoreduction and hyperthermic intra-peritoneal chemotherapy (HIPEC).

Baratti D, Kusamura S, Sironi A, Cabras A, Fumagalli L, Laterza B, Deraco M.

In Vivo. 2008 Jan-Feb;22(1):153-7.

3.

Multicystic peritoneal mesothelioma: outcomes and patho-biological features in a multi-institutional series treated by cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC).

Baratti D, Vaira M, Kusamura S, D'Amico S, Balestra MR, Cioppa T, Mingrone E, De Simone M, Deraco M.

Eur J Surg Oncol. 2010 Nov;36(11):1047-53. doi: 10.1016/j.ejso.2010.08.130. Epub 2010 Sep 15.

PMID:
20832234
4.

Diffuse malignant peritoneal mesothelioma: Failure analysis following cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC).

Baratti D, Kusamura S, Cabras AD, Dileo P, Laterza B, Deraco M.

Ann Surg Oncol. 2009 Feb;16(2):463-72. doi: 10.1245/s10434-008-0219-1. Epub 2008 Dec 12.

PMID:
19082859
5.

Peritoneal mesothelioma treated by induction chemotherapy, cytoreductive surgery, and intraperitoneal hyperthermic perfusion.

Deraco M, Casali P, Inglese MG, Baratti D, Pennacchioli E, Bertulli R, Kusamura S.

J Surg Oncol. 2003 Jul;83(3):147-53.

PMID:
12827682
6.

8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer.

Verwaal VJ, Bruin S, Boot H, van Slooten G, van Tinteren H.

Ann Surg Oncol. 2008 Sep;15(9):2426-32. doi: 10.1245/s10434-008-9966-2. Epub 2008 Jun 3.

PMID:
18521686
7.

Pseudomyxoma peritonei: clinical pathological and biological prognostic factors in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC).

Baratti D, Kusamura S, Nonaka D, Langer M, Andreola S, Favaro M, Gavazzi C, Laterza B, Deraco M.

Ann Surg Oncol. 2008 Feb;15(2):526-34. Epub 2007 Nov 28.

PMID:
18043976
8.

Peritoneal mesothelioma treated by cytoreductive surgery and intraperitoneal hyperthermic chemotherapy: results of a prospective study.

Brigand C, Monneuse O, Mohamed F, Sayag-Beaujard AC, Isaac S, Gilly FN, Glehen O.

Ann Surg Oncol. 2006 Mar;13(3):405-12. Epub 2006 Jan 30.

PMID:
16485159
9.

Recurrences after peritoneal carcinomatosis of colorectal origin treated by cytoreduction and hyperthermic intraperitoneal chemotherapy: location, treatment, and outcome.

Verwaal VJ, Boot H, Aleman BM, van Tinteren H, Zoetmulder FA.

Ann Surg Oncol. 2004 Apr;11(4):375-9. Epub 2004 Mar 15.

PMID:
15070596
10.

Prognostic analysis of clinicopathologic factors in 49 patients with diffuse malignant peritoneal mesothelioma treated with cytoreductive surgery and intraperitoneal hyperthermic perfusion.

Deraco M, Nonaka D, Baratti D, Casali P, Rosai J, Younan R, Salvatore A, Cabras Ad AD, Kusamura S.

Ann Surg Oncol. 2006 Feb;13(2):229-37. Epub 2006 Jan 18.

PMID:
16444562
11.
12.

Treatment of primary peritoneal mesothelioma by continuous hyperthermic peritoneal perfusion (CHPP).

Park BJ, Alexander HR, Libutti SK, Wu P, Royalty D, Kranda KC, Bartlett DL.

Ann Surg Oncol. 1999 Sep;6(6):582-90.

PMID:
10493628
13.

Outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal mesothelioma: the Australian experience.

Chua TC, Yan TD, Morris DL.

J Surg Oncol. 2009 Feb 1;99(2):109-13. doi: 10.1002/jso.21177.

PMID:
19016259
14.

Iterative procedures combining cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal recurrence: postoperative and long-term results.

Golse N, Bakrin N, Passot G, Mohamed F, Vaudoyer D, Gilly FN, Glehen O, Cotte E.

J Surg Oncol. 2012 Aug 1;106(2):197-203. doi: 10.1002/jso.23062. Epub 2012 Feb 13.

PMID:
22331814
15.

Treatment of peritoneal carcinomatosis from colonic cancer by cytoreduction, peritonectomy and hyperthermic intraperitoneal chemotherapy (HIPEC). Experience of ten years.

Vaira M, Cioppa T, D'Amico S, de Marco G, D'Alessandro M, Fiorentini G, De Simone M.

In Vivo. 2010 Jan-Feb;24(1):79-84.

PMID:
20133981
16.

Extensive surgical cytoreduction and intraoperative hyperthermic intraperitoneal chemotherapy in patients with pseudomyxoma peritonei.

Witkamp AJ, de Bree E, Kaag MM, van Slooten GW, van Coevorden F, Zoetmulder FA.

Br J Surg. 2001 Mar;88(3):458-63.

PMID:
11260116
17.

Clinical results of cytoreduction and HIPEC for malignant peritoneal mesothelioma.

Alexander HR, Hanna N, Pingpank JF.

Cancer Treat Res. 2007;134:343-55. Review.

PMID:
17633065
18.

Management of pseudomyxoma peritonei by cytoreduction+HIPEC (hyperthermic intraperitoneal chemotherapy): results analysis of a twelve-year experience.

Vaira M, Cioppa T, DE Marco G, Bing C, D'Amico S, D'Alessandro M, Fiorentini G, DE Simone M.

In Vivo. 2009 Jul-Aug;23(4):639-44.

19.

Lymph node metastases in diffuse malignant peritoneal mesothelioma.

Baratti D, Kusamura S, Cabras AD, Laterza B, Balestra MR, Deraco M.

Ann Surg Oncol. 2010 Jan;17(1):45-53. doi: 10.1245/s10434-009-0756-2. Epub 2009 Oct 24.

PMID:
19856030
20.

[Peritoneal mesothelioma: treatment with cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy].

Passot G, Cotte E, Brigand C, Beaujard AC, Isaac S, Gilly FN, Glehen O.

J Chir (Paris). 2008 Sep-Oct;145(5):447-53. French.

PMID:
19106865

Supplemental Content

Support Center